Conservative Versus Operative - First Time Shoulder Dislocations
Launched by COLUMBIA UNIVERSITY · Sep 4, 2022
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to treat people who have had a first-time shoulder dislocation. Researchers want to find out if surgery, specifically a procedure called arthroscopic Bankart repair, or physical therapy is more effective in helping patients recover. They are inviting individuals aged 12 and older who have been diagnosed with a primary anterior shoulder dislocation to participate in the trial. Participants will be randomly assigned to either the surgery group or the physical therapy group and will receive treatment accordingly.
If you or a family member are eligible and choose to participate, you can expect to receive either surgical treatment or physical therapy to help heal the shoulder. The goal is to see which option leads to better recovery outcomes. It's important to know that certain criteria may prevent people from joining the study, such as previous shoulder surgeries or specific health conditions. This trial is currently not recruiting participants, but it aims to provide valuable insights into the best treatment approaches for shoulder dislocations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients 12 and older
- • seen by the Columbia University Shoulder Elbow and Sports Medicine Service
- • first time anterior shoulder dislocation diagnosis
- Exclusion Criteria:
- • humeral avulsion during arthroscopy
- • bony defect \> 25% of glenoid surface
- • general anesthesia contraindication
- • previous shoulder surgery
- • inability or unwillingness to adhere to study participate
- • lost to follow up
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
David Trofa, MD
Principal Investigator
Assistant Professor of Orthopedic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials